Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers (Q73686704)
Jump to navigation
Jump to search
scientific article published on 01 July 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers |
scientific article published on 01 July 2003 |
Statements
Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers (English)
Joyce A O'Shaughnessy
Gary J Kelloff
Gary B Gordon
Ernest T Hawk
Caroline C Sigman